Skip to main content

Table 2 Clinical function scores of the three patient groups 2 years after surgery

From: Effect of switching administration of alendronate after teriparatide for the prevention of BMD loss around the implant after total hip arthroplasty, 2-year follow-up: a randomized controlled trial

 Switch groupALD groupControl groupP value
JOA score92.7 ± 7.197.7 ± 2.994.8 ± 5.7N.S.
UCLA activity score6.5 ± 0.76.1 ± 0.66.4 ± 1.0N.S.
HHS96.8 ± 4.198.5 ± 2.096.7 ± 4.1N.S.